EX1000

DRUG2 trials

Sponsors

Novo Nordisk A/S

Conditions

DiabetesDiabetes Mellitus, Type 2

Phase 2

Safety and Efficacy of Insulin NPH Compared to a New Insulin Formulation in Subjects With Type 2 Diabetes

CompletedNCT00660374

Novo Nordisk A/SDiabetes, Diabetes Mellitus, Type 2

Start: 2008-02-29End: 2009-03-31Updated: 2015-05-05

Safety and Efficacy of Biphasic Human Insulin Compared to EX1000 in Type 2 Diabetes

CompletedNCT00698802

Novo Nordisk A/SDiabetes, Diabetes Mellitus, Type 2

Start: 2008-06-30End: 2009-03-31Updated: 2015-04-14